工作场所大麻素检测的解读
Interpretation of Workplace Tests for Cannabinoids.
作者信息
Kulig Ken
机构信息
Toxicology Associates, Prof LLC, Denver, CO, USA.
出版信息
J Med Toxicol. 2017 Mar;13(1):106-110. doi: 10.1007/s13181-016-0587-z. Epub 2016 Sep 29.
Abstract
Workplace urine drug testing for an inactive THC metabolite is common in both federally regulated and non-regulated drug testing. A positive result does not document impairment, or even recent use, when impairment is likely the most important parameter being searched for by the drug testing procedure. Most cannabinoid testing does not detect imported synthetics. Currently, urine is the most widely tested matrix, but blood, plasma, oral fluid, and hair may also be accepted in federally regulated testing in the future. This article will discuss the history, the status quo, and the possible near term future of workplace testing for marijuana in employees.
摘要
在联邦监管和非监管的药物检测中，针对无活性四氢大麻酚代谢物的职场尿液药物检测都很常见。当药物检测程序可能最关注的重要参数是损伤时，阳性结果并不能证明存在损伤，甚至不能证明近期使用过药物。大多数大麻素检测无法检测出进口合成物。目前，尿液是检测最广泛的样本基质，但未来在联邦监管的检测中，血液、血浆、口腔液和毛发也可能被接受。本文将讨论员工职场大麻检测的历史、现状以及近期可能的发展趋势。
相似文献
1
Interpretation of Workplace Tests for Cannabinoids.工作场所大麻素检测的解读
J Med Toxicol. 2017 Mar;13(1):106-110. doi: 10.1007/s13181-016-0587-z. Epub 2016 Sep 29.
2
Marijuana in the Workplace: Guidance for Occupational Health Professionals and Employers: Joint Guidance Statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine.工作场所中的大麻：职业健康专业人员和雇主指南：美国职业健康护士协会与美国职业与环境医学学院联合指南声明
Workplace Health Saf. 2015 Apr;63(4):139-64. doi: 10.1177/2165079915581983. Epub 2015 Apr 10.
3
Workplace drug testing in Italy: findings about second-stage testing.意大利的职场药物检测：关于第二阶段检测的结果
Drug Test Anal. 2015 Mar;7(3):173-7. doi: 10.1002/dta.1640. Epub 2014 Mar 20.
4
Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.重组β-葡萄糖醛酸酶水解的优化及通过液相色谱串联质谱法定量测定八种尿中大麻素及其代谢物
Drug Test Anal. 2018 Mar;10(3):518-529. doi: 10.1002/dta.2230. Epub 2017 Aug 16.
5
The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.美国联邦工作场所药物检测计划强制指南：现状与未来考量
Forensic Sci Int. 2008 Jan 30;174(2-3):111-9. doi: 10.1016/j.forsciint.2007.03.008. Epub 2007 Apr 16.
6
Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.在吸食植物大麻与合成大麻素药物的个体中观察到的不同生理和行为线索。
Clin Toxicol (Phila). 2016;54(1):14-9. doi: 10.3109/15563650.2015.1101769.
7
Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens.尿液流行率、代谢物检测率、时间模式以及评估合适的 LC-MS/MS 检测目标以记录美国军事尿液样本中合成大麻素的摄入情况。
Clin Chem Lab Med. 2015 Feb;53(3):423-34. doi: 10.1515/cclm-2014-0612.
8
9
Workplace drug testing in Italy - critical considerations.意大利的工作场所药物检测——批判性思考。
Drug Test Anal. 2013 Apr;5(4):208-12. doi: 10.1002/dta.1458. Epub 2013 Jan 25.
10
[Urinary excretion of cannabis metabolites].[大麻代谢物的尿液排泄]
Tidsskr Nor Laegeforen. 1992 May 10;112(12):1585-6.
引用本文的文献
1
Rapid Screening of New Psychoactive Substances Using pDART-QqQ-MS.利用 pDART-QqQ-MS 进行新型精神活性物质的快速筛选。
J Am Soc Mass Spectrom. 2024 Jun 5;35(6):1370-1376. doi: 10.1021/jasms.4c00124. Epub 2024 Apr 23.
2
A national population-based study of cannabis use and correlates among U.S. veterans prescribed opioids in primary care.一项针对美国初级保健中开处阿片类药物的退伍军人的全国性基于人群的大麻使用及其相关因素的研究。
BMC Psychiatry. 2023 Mar 17;23(1):177. doi: 10.1186/s12888-023-04648-5.
3
Use of a Novel EEG-Based Objective Test, the Cognalyzer, in Quantifying the Strength and Determining the Action Time of Cannabis Psychoactive Effects and Factors that May Influence Them Within an Observational Study Framework.在一项观察性研究框架内，使用基于脑电图的新型客观测试工具Cognalyzer来量化大麻精神活性作用的强度、确定其作用时间以及可能影响这些作用的因素。
Neurol Ther. 2022 Mar;11(1):51-72. doi: 10.1007/s40120-021-00293-w. Epub 2021 Nov 2.
4
Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation.肺移植候选人选择的共识文件：国际心肺移植学会的更新。
J Heart Lung Transplant. 2021 Nov;40(11):1349-1379. doi: 10.1016/j.healun.2021.07.005. Epub 2021 Jul 24.
5
Preliminary Evidence for Cannabis and Nicotine Urinary Metabolites as Predictors of Verbal Memory Performance and Learning Among Young Adults.大麻和尼古丁尿液代谢物作为年轻成年人言语记忆表现和学习的预测指标的初步证据。
J Int Neuropsychol Soc. 2021 Jul;27(6):546-558. doi: 10.1017/S1355617721000205.
6
Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.口服和蒸发型 CBD 以及以 CBD 为主的蒸发型大麻给药后，大麻二酚（CBD）、Δ9-四氢大麻酚（THC）及其代谢物的尿药代谢动力学特征。
J Anal Toxicol. 2022 May 20;46(5):494-503. doi: 10.1093/jat/bkab059.
7
Workplace Cannabis Policies: A Moving Target.工作场所大麻政策：一个不断变化的目标。
Cannabis Cannabinoid Res. 2022 Feb;7(1):16-23. doi: 10.1089/can.2020.0095. Epub 2020 Nov 13.
8
Sensitivity, Specificity and Accuracy of a Novel EEG-Based Objective Test, the Cognalyzer, in Detecting Cannabis Psychoactive Effects.新型基于脑电图的客观测试，即 Cognalyzer，在检测大麻精神活性效应中的敏感性、特异性和准确性。
Adv Ther. 2021 May;38(5):2513-2531. doi: 10.1007/s12325-021-01718-6. Epub 2021 Apr 7.
9
Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution.医疗服务提供者与医用大麻患者之间关于转诊和药物替代的沟通。
J Cannabis Res. 2021 Jan 24;3(1):2. doi: 10.1186/s42238-021-00058-0.
10
Interpol review of toxicology 2016-2019.国际刑警组织2016 - 2019年毒理学综述
Forensic Sci Int Synerg. 2020 May 23;2:563-607. doi: 10.1016/j.fsisyn.2020.01.018. eCollection 2020.
本文引用的文献
1
A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.对使用合成大麻素及其相关治疗引发的不良事件的系统评价。
Clin Toxicol (Phila). 2016;54(1):1-13. doi: 10.3109/15563650.2015.1110590. Epub 2015 Nov 15.
2
Medical marijuana in the workplace: challenges and management options for occupational physicians.工作场所中的医用大麻：职业医生面临的挑战及管理选择
J Occup Environ Med. 2015 May;57(5):518-25. doi: 10.1097/JOM.0000000000000454.
3
Marijuana in the workplace: guidance for occupational health professionals and employers: Joint Guidance Statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine.工作场所中的大麻：给职业健康专业人员和雇主的指南：美国职业健康护士协会与美国职业与环境医学学院联合指南声明
J Occup Environ Med. 2015 Apr;57(4):459-75. doi: 10.1097/JOM.0000000000000441.
4
Residual cannabis levels in blood, urine and oral fluid following heavy cannabis use.大量使用大麻后血液、尿液和口腔液中的残留大麻水平。
Forensic Sci Int. 2015 Apr;249:173-80. doi: 10.1016/j.forsciint.2015.01.026. Epub 2015 Jan 30.
5
Non-smoker exposure to secondhand cannabis smoke. I. Urine screening and confirmation results.非吸烟者接触二手大麻烟雾。I. 尿液筛查与确认结果。
J Anal Toxicol. 2015 Jan-Feb;39(1):1-12. doi: 10.1093/jat/bku116. Epub 2014 Oct 17.
6
Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study.Δ9-四氢大麻二酚作为吸食大麻与服用屈大麻酚的标志物：一项临床研究结果
J Anal Toxicol. 2001 Oct;25(7):565-71. doi: 10.1093/jat/25.7.565.
7
Excretion patterns of cannabinoid metabolites after last use in a group of chronic users.
Clin Pharmacol Ther. 1985 Nov;38(5):572-8. doi: 10.1038/clpt.1985.226.
Zotero 插件